Guillaume Rey

Novartis (Switzerland)

Papers

1

Total Citations

26

H-Index

1

About

Guillaume Rey is a leading figure in bioprocess analytics and quality control for biopharmaceutical manufacturing, with a focus on automation and high-throughput detection methods. His most cited work, "Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals" (2012, 26 citations), represents a significant contribution to the field by demonstrating how to streamline critical impurity testing—specifically for host cell proteins and Protein A—using a fully automated, flexible ELISA platform. This innovation reduces manual labor and variability, enhancing reproducibility and regulatory compliance in biologics production. Rey’s research addresses a key bottleneck in bioprocessing: the need for robust, scalable analytical methods to ensure product purity and safety. By validating a turnkey automated system, he has provided a practical framework for industry adoption, impacting both academic research and commercial manufacturing. His work is essential for students and researchers interested in process analytical technology (PAT), quality by design (QbD), and the integration of automation into biopharmaceutical quality control, setting a benchmark for efficiency and reliability in impurity detection.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals
26 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago